# The next iteration of the AMP-T2D Knowledge Portal

> **NIH NIH UM1** · BROAD INSTITUTE, INC. · 2021 · $3,356,424

## Abstract

Abstract
 Despite much progress in mapping genetic associations for T2D, its complications, and related traits,
the underlying causal variants, effector genes, and gene networks are not well understood. The AMP-T2D
consortium aims to accelerate the pace by which these disease mechanisms are elucidated, through
generation and integration of novel genomic data interrogating genetic associations. This project addresses
RFA-DK-19-505 “Limited Competition for the Accelerating Medicines Partnership (AMP) in Type 2 Diabetes
Knowledge Portal (UM1)” and will be conducted by the leaders of the current AMP T2D Knowledge Portal
(T2DKP). Its goal is to continue development of the T2DKP by enhancing its infrastructure to aggregate,
analyze, and visualize genetic and genomic datasets and results, thereby helping to identify causal risk
variants and effector genes for T2D and its complications.
 The goal of specific aim 1 is to enhance the data and knowledge base for the T2DKP. It will enhance
the T2DKP software platform to represent additional classes of ‘omic and phenotypic data, integrate datasets
relevant to AMP-T2D within a federated data warehouse, develop new methods and analytical pipelines to
analyze these data, and enable them to be accessed by download or application programming interfaces
(APIs). The goal of specific aim 2 is to enhance the publicly accessible T2DKP web interface. It will develop
new web modules to visualize datasets within the T2DKP, extend the T2DKP with tools from external public
genomic databases, maintain curated knowledge lists for T2D and its complications, allow users to customize
data and tools shown within the T2DKP, and update the T2DKP in response to stakeholder feedback. The goal
of specific aim 3 is to coordinate the AMP-T2D consortium. It will provide operational support for AMP-T2D
investigators, foster collaborations with external partners, track and ensure the timely release of AMP-T2D
datasets, administer an opportunity pool to fund additional AMP-T2D projects, and conduct outreach and
training on the T2DKP.
 Significance: The project would extend the T2DKP with new capabilities to integrate and display
datasets with information regarding causal variants, effector transcripts, and gene networks for T2D and its
complications. Public access to these data and results will significantly accelerate efforts to identify new
therapeutic strategies to prevent, treat, or reverse T2D and its complications.

## Key facts

- **NIH application ID:** 10242932
- **Project number:** 5UM1DK105554-07
- **Recipient organization:** BROAD INSTITUTE, INC.
- **Principal Investigator:** MICHAEL L BOEHNKE
- **Activity code:** UM1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $3,356,424
- **Award type:** 5
- **Project period:** 2015-05-01 → 2025-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10242932

## Citation

> US National Institutes of Health, RePORTER application 10242932, The next iteration of the AMP-T2D Knowledge Portal (5UM1DK105554-07). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10242932. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*